This spatial alteration, together with the highly specific activation hierarchy of KLK14 by KLK5, but not by KLK7, via PAR-2, illustrates a precise mechanism within the kallikrein cascade that dictates tumor progression, indicating that different members of the same protease family exert distinct regulatory roles. The gene discussed is KLK4; the disease is neoplasm.